Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Related structures:
AlphaFold database: E9B1C5
Term | Name | Level | Count |
---|---|---|---|
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0016925 | protein sumoylation | 7 | 1 |
GO:0018193 | peptidyl-amino acid modification | 5 | 1 |
GO:0018205 | peptidyl-lysine modification | 6 | 1 |
GO:0019538 | protein metabolic process | 3 | 1 |
GO:0032446 | protein modification by small protein conjugation | 6 | 1 |
GO:0036211 | protein modification process | 4 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043412 | macromolecule modification | 4 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0070647 | protein modification by small protein conjugation or removal | 5 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 9 |
GO:0008270 | zinc ion binding | 6 | 9 |
GO:0043167 | ion binding | 2 | 9 |
GO:0043169 | cation binding | 3 | 9 |
GO:0046872 | metal ion binding | 4 | 9 |
GO:0046914 | transition metal ion binding | 5 | 9 |
GO:0003824 | catalytic activity | 1 | 1 |
GO:0016740 | transferase activity | 2 | 1 |
GO:0019787 | ubiquitin-like protein transferase activity | 3 | 1 |
GO:0019789 | SUMO transferase activity | 4 | 1 |
GO:0061659 | ubiquitin-like protein ligase activity | 4 | 1 |
GO:0061665 | SUMO ligase activity | 5 | 1 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 113 | 115 | PF00675 | 0.406 |
CLV_NRD_NRD_1 | 233 | 235 | PF00675 | 0.587 |
CLV_NRD_NRD_1 | 51 | 53 | PF00675 | 0.515 |
CLV_PCSK_KEX2_1 | 113 | 115 | PF00082 | 0.404 |
CLV_PCSK_KEX2_1 | 16 | 18 | PF00082 | 0.730 |
CLV_PCSK_KEX2_1 | 232 | 234 | PF00082 | 0.590 |
CLV_PCSK_KEX2_1 | 51 | 53 | PF00082 | 0.579 |
CLV_PCSK_PC1ET2_1 | 16 | 18 | PF00082 | 0.782 |
CLV_PCSK_PC1ET2_1 | 232 | 234 | PF00082 | 0.689 |
CLV_PCSK_PC7_1 | 12 | 18 | PF00082 | 0.766 |
CLV_PCSK_SKI1_1 | 113 | 117 | PF00082 | 0.382 |
CLV_PCSK_SKI1_1 | 186 | 190 | PF00082 | 0.472 |
CLV_PCSK_SKI1_1 | 345 | 349 | PF00082 | 0.551 |
CLV_PCSK_SKI1_1 | 52 | 56 | PF00082 | 0.481 |
CLV_PCSK_SKI1_1 | 68 | 72 | PF00082 | 0.260 |
CLV_Separin_Metazoa | 56 | 60 | PF03568 | 0.518 |
DEG_APCC_DBOX_1 | 113 | 121 | PF00400 | 0.394 |
DEG_APCC_DBOX_1 | 51 | 59 | PF00400 | 0.530 |
DEG_APCC_DBOX_1 | 67 | 75 | PF00400 | 0.266 |
DOC_CYCLIN_RxL_1 | 111 | 121 | PF00134 | 0.527 |
DOC_CYCLIN_yClb5_NLxxxL_5 | 86 | 95 | PF00134 | 0.540 |
DOC_CYCLIN_yCln2_LP_2 | 343 | 349 | PF00134 | 0.528 |
DOC_MAPK_gen_1 | 113 | 120 | PF00069 | 0.386 |
DOC_MAPK_gen_1 | 48 | 57 | PF00069 | 0.538 |
DOC_MAPK_MEF2A_6 | 113 | 120 | PF00069 | 0.393 |
DOC_MAPK_MEF2A_6 | 170 | 177 | PF00069 | 0.453 |
DOC_MAPK_MEF2A_6 | 186 | 195 | PF00069 | 0.236 |
DOC_PP2B_LxvP_1 | 116 | 119 | PF13499 | 0.408 |
DOC_PP2B_LxvP_1 | 95 | 98 | PF13499 | 0.544 |
DOC_USP7_MATH_1 | 10 | 14 | PF00917 | 0.702 |
DOC_USP7_MATH_1 | 273 | 277 | PF00917 | 0.494 |
DOC_USP7_MATH_1 | 303 | 307 | PF00917 | 0.568 |
DOC_USP7_MATH_1 | 325 | 329 | PF00917 | 0.564 |
DOC_USP7_UBL2_3 | 348 | 352 | PF12436 | 0.551 |
DOC_WW_Pin1_4 | 107 | 112 | PF00397 | 0.559 |
DOC_WW_Pin1_4 | 147 | 152 | PF00397 | 0.437 |
DOC_WW_Pin1_4 | 158 | 163 | PF00397 | 0.436 |
DOC_WW_Pin1_4 | 175 | 180 | PF00397 | 0.374 |
DOC_WW_Pin1_4 | 20 | 25 | PF00397 | 0.718 |
DOC_WW_Pin1_4 | 238 | 243 | PF00397 | 0.692 |
DOC_WW_Pin1_4 | 69 | 74 | PF00397 | 0.378 |
LIG_14-3-3_CanoR_1 | 225 | 231 | PF00244 | 0.578 |
LIG_Actin_WH2_2 | 332 | 350 | PF00022 | 0.487 |
LIG_BIR_III_2 | 42 | 46 | PF00653 | 0.631 |
LIG_FHA_1 | 172 | 178 | PF00498 | 0.361 |
LIG_FHA_1 | 267 | 273 | PF00498 | 0.508 |
LIG_FHA_1 | 359 | 365 | PF00498 | 0.714 |
LIG_FHA_1 | 9 | 15 | PF00498 | 0.631 |
LIG_FHA_2 | 132 | 138 | PF00498 | 0.626 |
LIG_FHA_2 | 98 | 104 | PF00498 | 0.641 |
LIG_LIR_Apic_2 | 127 | 133 | PF02991 | 0.471 |
LIG_LIR_Gen_1 | 72 | 83 | PF02991 | 0.478 |
LIG_LIR_Nem_3 | 185 | 191 | PF02991 | 0.256 |
LIG_LIR_Nem_3 | 203 | 208 | PF02991 | 0.405 |
LIG_LIR_Nem_3 | 72 | 78 | PF02991 | 0.324 |
LIG_MAD2 | 348 | 356 | PF02301 | 0.600 |
LIG_PCNA_yPIPBox_3 | 310 | 324 | PF02747 | 0.467 |
LIG_SH2_GRB2like | 146 | 149 | PF00017 | 0.428 |
LIG_SH2_STAT5 | 146 | 149 | PF00017 | 0.536 |
LIG_SH2_STAT5 | 278 | 281 | PF00017 | 0.550 |
LIG_SH2_STAT5 | 337 | 340 | PF00017 | 0.525 |
LIG_SH3_3 | 149 | 155 | PF00018 | 0.418 |
LIG_SH3_3 | 67 | 73 | PF00018 | 0.420 |
LIG_SUMO_SIM_anti_2 | 361 | 370 | PF11976 | 0.707 |
LIG_SUMO_SIM_par_1 | 173 | 178 | PF11976 | 0.435 |
LIG_SUMO_SIM_par_1 | 250 | 256 | PF11976 | 0.537 |
LIG_SUMO_SIM_par_1 | 360 | 370 | PF11976 | 0.628 |
LIG_TRAF2_1 | 36 | 39 | PF00917 | 0.666 |
MOD_CDC14_SPxK_1 | 110 | 113 | PF00782 | 0.546 |
MOD_CDC14_SPxK_1 | 161 | 164 | PF00782 | 0.597 |
MOD_CDK_SPxK_1 | 107 | 113 | PF00069 | 0.568 |
MOD_CDK_SPxK_1 | 158 | 164 | PF00069 | 0.587 |
MOD_CDK_SPxxK_3 | 107 | 114 | PF00069 | 0.561 |
MOD_CK1_1 | 19 | 25 | PF00069 | 0.676 |
MOD_CK1_1 | 241 | 247 | PF00069 | 0.684 |
MOD_CK2_1 | 131 | 137 | PF00069 | 0.572 |
MOD_CK2_1 | 242 | 248 | PF00069 | 0.682 |
MOD_CK2_1 | 97 | 103 | PF00069 | 0.623 |
MOD_GlcNHglycan | 18 | 21 | PF01048 | 0.739 |
MOD_GlcNHglycan | 195 | 198 | PF01048 | 0.562 |
MOD_GlcNHglycan | 26 | 29 | PF01048 | 0.732 |
MOD_GlcNHglycan | 305 | 308 | PF01048 | 0.460 |
MOD_GSK3_1 | 120 | 127 | PF00069 | 0.408 |
MOD_GSK3_1 | 15 | 22 | PF00069 | 0.719 |
MOD_GSK3_1 | 171 | 178 | PF00069 | 0.459 |
MOD_GSK3_1 | 238 | 245 | PF00069 | 0.699 |
MOD_GSK3_1 | 86 | 93 | PF00069 | 0.431 |
MOD_N-GLC_1 | 147 | 152 | PF02516 | 0.457 |
MOD_N-GLC_1 | 64 | 69 | PF02516 | 0.284 |
MOD_NEK2_1 | 141 | 146 | PF00069 | 0.503 |
MOD_NEK2_1 | 255 | 260 | PF00069 | 0.295 |
MOD_NEK2_1 | 63 | 68 | PF00069 | 0.484 |
MOD_NEK2_1 | 91 | 96 | PF00069 | 0.504 |
MOD_NEK2_2 | 273 | 278 | PF00069 | 0.191 |
MOD_PIKK_1 | 325 | 331 | PF00454 | 0.425 |
MOD_PKA_1 | 16 | 22 | PF00069 | 0.784 |
MOD_PKA_2 | 16 | 22 | PF00069 | 0.755 |
MOD_Plk_1 | 255 | 261 | PF00069 | 0.553 |
MOD_Plk_1 | 64 | 70 | PF00069 | 0.485 |
MOD_Plk_4 | 141 | 147 | PF00069 | 0.494 |
MOD_ProDKin_1 | 107 | 113 | PF00069 | 0.550 |
MOD_ProDKin_1 | 147 | 153 | PF00069 | 0.444 |
MOD_ProDKin_1 | 158 | 164 | PF00069 | 0.435 |
MOD_ProDKin_1 | 175 | 181 | PF00069 | 0.370 |
MOD_ProDKin_1 | 20 | 26 | PF00069 | 0.721 |
MOD_ProDKin_1 | 238 | 244 | PF00069 | 0.689 |
MOD_ProDKin_1 | 69 | 75 | PF00069 | 0.380 |
MOD_SUMO_for_1 | 309 | 312 | PF00179 | 0.512 |
TRG_DiLeu_BaEn_1 | 87 | 92 | PF01217 | 0.277 |
TRG_ENDOCYTIC_2 | 75 | 78 | PF00928 | 0.397 |
TRG_ER_diArg_1 | 113 | 115 | PF00400 | 0.411 |
TRG_ER_diArg_1 | 318 | 321 | PF00400 | 0.427 |
TRG_NES_CRM1_1 | 203 | 218 | PF08389 | 0.499 |
TRG_NLS_MonoExtC_3 | 231 | 236 | PF00514 | 0.549 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0S4JLR1 | Bodo saltans | 37% | 66% |
A0A1X0P185 | Trypanosomatidae | 45% | 67% |
A0A3R7KHL3 | Trypanosoma rangeli | 45% | 72% |
A0A3S7X3Z5 | Leishmania donovani | 91% | 100% |
C9ZRF8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 44% | 70% |
Q4Q6T7 | Leishmania major | 91% | 100% |
V5BSC2 | Trypanosoma cruzi | 47% | 72% |